Clinical Trials Community

Welcome to the Clinical Trials Community

Did You Know..?

1/3 of patients don't respond

1/3 of patients don't respond
to initial IBD treatments, which
makes new trials a vital part
of developing new treatments

60% lose responsiveness

60% lose responsiveness
to an IBD treatment over time
and need to have other
treatments available to them

Let's work together to spread the word about clinical trials and get our community to understand the benefit and how trials can help make a positive impact to so many dealing with IBD.

Explore the Clinical Trials Community

Paige's Story

"When I was diagnosed with ulcerative colitis as a twenty-year old, I never thought I would go so far as enrolling in a clinical trial to manage my disease."

Read Paige's Story
Watch Patient Videos

Hear from IBD patients and others as they describe their own personal journey with clinical trials and how it transformed their ability to manage IBD symptoms.

Watch Patient Videos
Search Clinical Trials

Trials help facilitate research and accelerate the development of new drugs and treatments for patients. Search our clinical trial to find one that best suit your particular needs!

Search Clinical Trials
Get Resources

The Foundation has curated a great number of resources for you to learn more about the ins and outs of clinical trials, why they are so important, and how your participation helps.

Get Resources

Research Updates

sd

PROPS: Patient Reported Outcomes after Pouch Surgery Delphi Consensus Study


Posted by: Liliana Bordeianou, MD and Paul Cavallaro, MD

Blog type

Why are we doing this study? Patients who undergo a proctocolectomy with ileal pouch-anal anastomosis (also known as a j-pouch, though other configurations can also be built such as S or W) sometimes experience significant changes in their bowel habits after their surgeries. But there are many other potential changes to a patient’s life that doctors may not be aware of. Our goal for the PROPS Delphi Consensus Study is to seek direct input from patients, gastroenterologists, and surgeons to determine what these additional factors of living with a pouch may be.

Read More »

rk

Addressing unmet patient needs in IBD research

January 28, 2019
Posted by: Rebecca Kaplan

For over five decades, the Crohn’s & Colitis Foundation has been leading the charge to find cures for Crohn’s disease and ulcerative colitis, and to improve the quality of life for patients. We’ve made incredible strides through our research initiatives, including:

Read More »

neeragupta

The Sixth Annual Pediatric IBD Research Day at Weill Cornell Medicine (#PIBDRD18) will highlight scientific advances and gaps in knowledge in pediatric IBD research. The program will include presentations by nationally and internationally recognized experts, followed by question and answer periods.

Read More »

ctcrgb

Crohn’s & Colitis Foundation Research Priorities: Challenges in IBD Research

January 24, 2018
Posted by: Clinical Trials Community

Blog type

The Crohn’s & Colitis Foundation is dedicated to overcoming hurdles and accelerating innovation towards real-world improvement in IBD care. To accomplish this, every five years the Foundation updates its priorities in inflammatory bowel diseases (IBD) research, through a process entitled Challenges in IBD Research. Challenges in IBD Research recommends a global research agenda for the IBD community and guides the Foundation’s funding priorities.

Read More »

balfour

We are pleased to announce that the Crohn’s & Colitis Foundation recently received a donation of $5 million from the Litwin Family. The Litwin IBD Pioneers Initiative, formerly the Broad Medical Research Program, supports researchers throughout the world by funding highly innovative pilot IBD research studies that focus on improving IBD management, including developing new diagnostic and treatment options, predicting clinically relevant disease subsets and identifying noninvasive markers of disease activity of Crohn’s disease and ulcerative colitis.

Read More »

This educational initiative is made possible by support from: